|
|
||||||||
From the Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Abstract
The treatment of 224 patients with invasive squamous cell carcinoma of the vulva over a 20-year interval at the Mayo Clinic resulted in an overall survival rate of 75%, compared with 89% for age-matched controls. For patients with stage I disease, 5-year survival was 90%; for those with stages II, III, and IV, it was 81, 68, and 20%, respectively. A precipitous decline in survival rates was noted when metastases to regional nodes were encountered, when lesion size was more than 3 cm, arid when histologic dedifferentiation exceeded grade 2. Incorrect clinical staging efforts were observed in 25% of the cases, so the necessity for surgical staging was apparent.
This article has been cited by other articles:
![]() |
T. Le, R. Elsugi, L. Hopkins, W. Faught, and M. Fung-Kee-Fung The Definition of Optimal Inguinal Femoral Nodal Dissection in the Management of Vulva Squamous Cell Carcinoma Ann. Surg. Oncol., July 1, 2007; 14(7): 2128 - 2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Stehman and K. Y. Look Carcinoma of the vulva. Obstet. Gynecol., March 1, 2006; 107(3): 719 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. A. Sohaib, P. S. Richards, T. Ind, A. R. Jeyarajah, J. H. Shepherd, I. J. Jacobs, and R. H. Reznek MR Imaging of Carcinoma of the Vulva Am. J. Roentgenol., February 1, 2002; 178(2): 373 - 377. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |